TEVA logo

TEVA CAPEX

Annual CAPEX

$498.00 M
-$28.00 M-5.32%

December 31, 2024


Summary


Performance

TEVA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

Quarterly CAPEX

$129.00 M
-$19.00 M-12.84%

December 31, 2024


Summary


Performance

TEVA Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

TTM CAPEX

$498.00 M
+$10.00 M+2.05%

December 31, 2024


Summary


Performance

TEVA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAcash flowmetrics:

TEVA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.3%+4.0%-2.5%
3 y3 years-11.4%+1.6%-14.6%
5 y5 years-5.1%-26.7%-13.8%

TEVA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.4%at low-17.8%+33.0%-14.6%+2.0%
5 y5-year-13.8%at low-26.7%+33.0%-17.0%+2.0%
alltimeall time-54.9%+2133.2%-61.3%+451.7%-55.6%+2029.8%

Teva Pharmaceutical Industries Limited CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$498.00 M(-5.3%)
$129.00 M(-12.8%)
$498.00 M(+2.0%)
Sep 2024
-
$148.00 M(+52.6%)
$488.00 M(-0.2%)
Jun 2024
-
$97.00 M(-21.8%)
$489.00 M(-4.3%)
Mar 2024
-
$124.00 M(+4.2%)
$511.00 M(-2.9%)
Dec 2023
$526.00 M(-4.0%)
$119.00 M(-20.1%)
$526.00 M(-4.2%)
Sep 2023
-
$149.00 M(+25.2%)
$549.00 M(+5.2%)
Jun 2023
-
$119.00 M(-14.4%)
$522.00 M(-1.5%)
Mar 2023
-
$139.00 M(-2.1%)
$530.00 M(-3.3%)
Dec 2022
$548.00 M(-2.5%)
$142.00 M(+16.4%)
$548.00 M(-2.0%)
Sep 2022
-
$122.00 M(-3.9%)
$559.00 M(-4.1%)
Jun 2022
-
$127.00 M(-19.1%)
$583.00 M(+2.5%)
Mar 2022
-
$157.00 M(+2.6%)
$569.00 M(+1.2%)
Dec 2021
$562.00 M(-2.8%)
$153.00 M(+4.8%)
$562.00 M(-3.9%)
Sep 2021
-
$146.00 M(+29.2%)
$585.00 M(+0.5%)
Jun 2021
-
$113.00 M(-24.7%)
$582.00 M(-3.0%)
Mar 2021
-
$150.00 M(-14.8%)
$600.00 M(+3.8%)
Dec 2020
$578.00 M(+10.1%)
$176.00 M(+23.1%)
$578.00 M(+10.9%)
Sep 2020
-
$143.00 M(+9.2%)
$521.00 M(-4.8%)
Jun 2020
-
$131.00 M(+2.3%)
$547.00 M(+3.6%)
Mar 2020
-
$128.00 M(+7.6%)
$528.00 M(+0.6%)
Dec 2019
$525.00 M(-19.4%)
$119.00 M(-29.6%)
$525.00 M(-15.2%)
Sep 2019
-
$169.00 M(+50.9%)
$619.00 M(+5.1%)
Jun 2019
-
$112.00 M(-10.4%)
$589.00 M(-3.9%)
Mar 2019
-
$125.00 M(-41.3%)
$613.00 M(-5.8%)
Dec 2018
$651.00 M(-25.5%)
$213.00 M(+53.2%)
$651.00 M(-7.7%)
Sep 2018
-
$139.00 M(+2.2%)
$705.00 M(-9.4%)
Jun 2018
-
$136.00 M(-16.6%)
$778.00 M(-6.8%)
Mar 2018
-
$163.00 M(-39.0%)
$835.00 M(-4.5%)
Dec 2017
$874.00 M(-3.0%)
$267.00 M(+25.9%)
$874.00 M(-7.0%)
Sep 2017
-
$212.00 M(+9.8%)
$940.00 M(-0.9%)
Jun 2017
-
$193.00 M(-4.5%)
$949.00 M(+1.9%)
Mar 2017
-
$202.00 M(-39.3%)
$931.00 M(+3.3%)
Dec 2016
$901.00 M(+16.7%)
$333.00 M(+50.7%)
$901.00 M(+10.4%)
Sep 2016
-
$221.00 M(+26.3%)
$816.00 M(+6.7%)
Jun 2016
-
$175.00 M(+1.7%)
$765.00 M(+0.8%)
Mar 2016
-
$172.00 M(-30.6%)
$759.00 M(-1.7%)
Dec 2015
$772.00 M(-16.9%)
$248.00 M(+45.9%)
$772.00 M(-6.3%)
Sep 2015
-
$170.00 M(+0.6%)
$824.00 M(-4.8%)
Jun 2015
-
$169.00 M(-8.6%)
$866.00 M(-2.6%)
Mar 2015
-
$185.00 M(-38.3%)
$889.00 M(-4.3%)
Dec 2014
$929.00 M(-9.9%)
$300.00 M(+41.5%)
$929.00 M(-1.5%)
Sep 2014
-
$212.00 M(+10.4%)
$943.00 M(-1.7%)
Jun 2014
-
$192.00 M(-14.7%)
$959.00 M(-3.3%)
Mar 2014
-
$225.00 M(-28.3%)
$992.00 M(-3.8%)
Dec 2013
$1.03 B(-6.6%)
$314.00 M(+37.7%)
$1.03 B(-1.2%)
Sep 2013
-
$228.00 M(+1.3%)
$1.04 B(-2.0%)
Jun 2013
-
$225.00 M(-14.8%)
$1.06 B(-2.7%)
Mar 2013
-
$264.00 M(-19.3%)
$1.09 B(-0.9%)
Dec 2012
$1.10 B(+4.8%)
$327.00 M(+31.3%)
$1.10 B(+0.9%)
Sep 2012
-
$249.00 M(-2.0%)
$1.09 B(-2.4%)
Jun 2012
-
$254.00 M(-7.3%)
$1.12 B(+2.6%)
Mar 2012
-
$274.00 M(-13.6%)
$1.09 B(+3.8%)
DateAnnualQuarterlyTTM
Dec 2011
$1.05 B(+48.3%)
$317.00 M(+14.9%)
$1.05 B(+8.6%)
Sep 2011
-
$276.00 M(+22.1%)
$970.00 M(+11.6%)
Jun 2011
-
$226.00 M(-3.4%)
$869.00 M(+11.6%)
Mar 2011
-
$234.00 M(0.0%)
$779.00 M(+9.7%)
Dec 2010
$710.00 M(-1.3%)
$234.00 M(+33.7%)
$710.00 M(+3.2%)
Sep 2010
-
$175.00 M(+28.7%)
$688.00 M(-3.0%)
Jun 2010
-
$136.00 M(-17.6%)
$709.00 M(-19.8%)
Mar 2010
-
$165.00 M(-22.2%)
$884.00 M(+22.9%)
Dec 2009
$719.00 M(+5.6%)
$212.00 M(+8.2%)
$719.00 M(+4.5%)
Sep 2009
-
$196.00 M(-37.0%)
$688.00 M(+2.7%)
Jun 2009
-
$311.00 M(+71.8%)
$670.00 M(-1.6%)
Dec 2008
$681.00 M(+25.6%)
$181.00 M(+1.7%)
$681.00 M(+5.1%)
Sep 2008
-
$178.00 M(-1.1%)
$648.00 M(+8.4%)
Jun 2008
-
$180.00 M(+26.8%)
$598.00 M(+13.3%)
Mar 2008
-
$142.00 M(-4.1%)
$528.00 M(-2.6%)
Dec 2007
$542.00 M(+39.0%)
$148.00 M(+15.6%)
$542.00 M(+5.9%)
Sep 2007
-
$128.00 M(+16.4%)
$511.90 M(+6.3%)
Jun 2007
-
$110.00 M(-29.5%)
$481.60 M(+1.6%)
Mar 2007
-
$156.00 M(+32.3%)
$474.00 M(+21.5%)
Dec 2006
$390.00 M(+25.8%)
$117.90 M(+20.7%)
$390.00 M(+9.8%)
Sep 2006
-
$97.70 M(-4.6%)
$355.30 M(+4.3%)
Jun 2006
-
$102.40 M(+42.2%)
$340.70 M(+11.8%)
Mar 2006
-
$72.00 M(-13.5%)
$304.70 M(-1.7%)
Dec 2005
$310.00 M(-0.3%)
$83.20 M(+0.1%)
$310.00 M(-5.0%)
Sep 2005
-
$83.10 M(+25.2%)
$326.20 M(+2.5%)
Jun 2005
-
$66.40 M(-14.1%)
$318.10 M(-1.9%)
Mar 2005
-
$77.30 M(-22.2%)
$324.20 M(+4.2%)
Dec 2004
$311.00 M(+49.9%)
$99.40 M(+32.5%)
$311.00 M(+12.4%)
Sep 2004
-
$75.00 M(+3.4%)
$276.60 M(+6.6%)
Jun 2004
-
$72.50 M(+13.1%)
$259.50 M(+10.6%)
Mar 2004
-
$64.10 M(-1.4%)
$234.70 M(+13.1%)
Dec 2003
$207.50 M(+29.4%)
$65.00 M(+12.3%)
$207.50 M(+7.5%)
Sep 2003
-
$57.90 M(+21.4%)
$193.00 M(+15.1%)
Jun 2003
-
$47.70 M(+29.3%)
$167.70 M(-0.4%)
Mar 2003
-
$36.90 M(-26.9%)
$168.30 M(+4.9%)
Dec 2002
$160.40 M(+19.6%)
$50.50 M(+54.9%)
$160.40 M(+4.9%)
Sep 2002
-
$32.60 M(-32.5%)
$152.97 M(+0.9%)
Jun 2002
-
$48.30 M(+66.6%)
$151.65 M(+8.6%)
Mar 2002
-
$29.00 M(-32.7%)
$139.68 M(+4.2%)
Dec 2001
$134.07 M(+49.9%)
$43.07 M(+37.7%)
$134.07 M(+47.3%)
Sep 2001
-
$31.28 M(-13.9%)
$91.00 M(+52.4%)
Jun 2001
-
$36.34 M(+55.4%)
$59.72 M(+155.4%)
Mar 2001
-
$23.38 M
$23.38 M
Dec 2000
$89.42 M(+33.3%)
-
-
Dec 1999
$67.07 M(+22.0%)
-
-
Dec 1998
$54.98 M(-13.3%)
-
-
Dec 1997
$63.40 M(-53.1%)
-
-
Dec 1996
$135.30 M(+11.2%)
-
-
Dec 1995
$121.70 M(+35.8%)
-
-
Dec 1994
$89.60 M(+97.8%)
-
-
Dec 1993
$45.30 M(-7.0%)
-
-
Dec 1992
$48.70 M(+118.4%)
-
-
Dec 1991
$22.30 M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual capital expenditures?
  • What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
  • What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?

What is Teva Pharmaceutical Industries Limited annual capital expenditures?

The current annual CAPEX of TEVA is $498.00 M

What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual capital expenditures is $1.10 B

What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?

Over the past year, TEVA annual capital expenditures has changed by -$28.00 M (-5.32%)

What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?

The current quarterly CAPEX of TEVA is $129.00 M

What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly capital expenditures is $333.00 M

What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?

Over the past year, TEVA quarterly capital expenditures has changed by +$5.00 M (+4.03%)

What is Teva Pharmaceutical Industries Limited TTM capital expenditures?

The current TTM CAPEX of TEVA is $498.00 M

What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM capital expenditures is $1.12 B

What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?

Over the past year, TEVA TTM capital expenditures has changed by -$13.00 M (-2.54%)